688276 logo

Changchun BCHT Biotechnology Co. Stock Price

SHSE:688276 Community·CN¥9.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

688276 Share Price Performance

CN¥0
-26.93 (-100.00%)
CN¥0
-26.93 (-100.00%)
Price CN¥0

688276 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with adequate balance sheet.

1 Risk
1 Reward

Changchun BCHT Biotechnology Co. Key Details

CN¥677.5m

Revenue

CN¥173.9m

Cost of Revenue

CN¥503.6m

Gross Profit

CN¥674.1m

Other Expenses

-CN¥170.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.41
74.33%
-25.17%
6.9%
View Full Analysis

About 688276

Founded
2004
Employees
1266
CEO
Chunlai Jiang
WebsiteView website
www.bchtpharm.com

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.

Recent 688276 News & Updates

Recent updates

No updates